InvestorNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Appoints Technology Innovator to Lead MedCheks LLC

February 9, 2021 12:55 PM EST

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health care platform, today announced its appointment of technology entrepreneur and industry thought leader James Ram to lead the company’s newly launched MedCheks LLC subsidiary. This move is part of the company’s efforts to bring a Digital Health Passport to market – allowing the holder to display vaccination status and test results for travel or access to events and public facilities. James Ram brings to Trxade more than 25 years of leadership experience in the travel, tourism and location-based entertainment industry. “I am pleased to announce the introduction of MedCheks and its first product, a Digital Health Passport, allowing the global economy the means by which to safely reopen,” said Suren Ajjarapu, chief executive officer of Trxade Group. “Finding a technology leader with a successful track record in innovation like James Ram was critical, as his broad experience with privacy, security and excellent global reputation will prove important as we launch this exciting new product.”

To view the full press release, visit https://ibn.fm/S0zw4

About Trxade Group, Inc.

Headquartered in Tampa, Florida, Trxade Group is an integrated drug procurement, delivery and health care platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making health care services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms: (1) the Trxade B2B trading platform with around 11,800 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit www.Trxade.comwww.BonumHealth.com and www.medcheks.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Investor Brand Network, Press Releases